Agents such as GLP-1 receptor agonists used in the management of postbariatric hypoglycemia are efficacious in TPIAT-associated hypoglycemia, particularly if the hypoglycemia is postprandial. This evidence concerns the gene GLP1R and Hypoglycemia.